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We present two recent successfully litigated malpractice cases in which patients with 
cerebrovascular accidents were misdiagnosed as stroke mimics. The first was diagnosed as a 
hemiplegic migraine, which occurs in only 0.01% of the population. The second was diagnosed as a 
conversion disorder, which ultimately has a neurologic etiology in 4% of cases. In both cases, issues 
of poor patient communication and poor documentation were paramount in the legal outcome. We 
discuss caveats of stroke mimics, tissue plasminogen activator administration liability, and pitfalls in 
patient and family interactions. [Clin Pract Cases Emerg Med. 2019;3(3):194-198.]
CASE REPORT 
Case 1: Estate of Smith versus Baca, Turner, and Augusta 
Emergency Physicians – Virginia1
A 40-year-old female was visiting her family when she 
had sudden onset of severe headache, with associated slurred 
speech, right-sided weakness, dizziness, nausea and vomiting. 
Her mother called emergency medical services (EMS) within 
five minutes and told the dispatcher she was concerned her 
daughter was having a stroke. EMS arrived at the home 40 
minutes later, and the patient arrived at the hospital two hours 
and twenty minutes after onset of her symptoms. Transport 
was lengthy because the patient lived in a remote location. 
Although EMS initially considered flying her from the scene, 
they were forced to use ground transport due to poor weather; 
however, the paramedic on scene stated she complained only 
of headache and right-sided tingling. He performed a 
Cincinnati Prehospital Stroke Scale nine times during transfer, 
all of which were documented as normal.
On emergency department (ED) arrival, the patient was 
accepted from EMS by a nurse and the supervising 
emergency physician (EP), and was evaluated shortly 
afterward. Prochlorperazine, diphenhydramine, and 
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dexamethasone were ordered to treat the patient’s headache, 
and a non-contrast computed tomography (CT) of the head 
was obtained. The EP diagnosed the patient with a complex 
migraine headache. It was documented but later disputed that 
her headache improved; however, while in the ED her 
symptoms changed. Her paresthesia moved to the left side, 
and five hours and ten minutes after onset of symptoms, a 
neurologist was consulted by phone and recommended 
magnetic resonance imaging (MRI), with a plan to see the 
patient in the hospital the next day. The MRI revealed an 
ischemic cerebrovascular accident (CVA). The patient died 
of complications three days later. 
The plaintiff alleged that the EP should have initiated a 
stroke alert and consulted a neurologist immediately on arrival 
due to the patient’s history of symptoms at home, which could 
have been consistent with CVA. The hospital is a primary 
stroke center and had a tele-neurologist available. It was 
asserted that if the CVA had been identified and tissue 
plasminogen activator (tPA) administered within the accepted 
4.5-hour window, Ms. Smith would have survived. The 
plaintiff also claimed that failure to identify and treat CVA 
was a departure from standard of care. Another EP who 
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What do we already know about this clinical 
entity? 
Conversion disorder and hemiplegic 
migraine are diagnoses of exclusion after 
cerebrovascular accident has been ruled out.
 
What is the major learning point? 
Tissue plasminogen activator (tPA) malpractice 
cases more often arise from not using it for 
stroke mimics, rather than complications from 
using it. Documenting is key.
 
How might this improve emergency 
medicine practice? 
Litigation is less likely when there has 
been full consideration of diagnoses, and 
discussion with patients and families of the 
risks and benefits of administering tPA. 
participated briefly the next morning and the neurologist were 
dropped from the case, as they were only involved after the 
tPA window had expired. 
Furthermore, the family of the decedent asserted that they 
were concerned for stroke and requested multiple times that 
the patient be evaluated for stroke. Her mother was quoted in 
testimony as saying, “I want [the EP] to give her ‘that shot’” 
during the patient’s ED stay.
The EP and his defense team asserted that the decedent 
had a normal neurologic exam, with the exception of 
headache and arm tingling, which is not consistent with 
CVA. Her neurologic symptoms resolved rapidly and were 
associated with headache, which is consistent with the 
diagnosis of complex migraine. Furthermore, they alleged 
that even if CVA were thought to be the cause, the decedent 
would not have qualified for treatment with tPA based on 
accepted inclusion criteria. In fact, the experts testified that 
tPA is a potentially dangerous drug that has no scientific 
evidence of decreasing mortality; however, at least one jury 
member stated that the discussion of several, well-
publicized tPA studies by the defense had the opposite 
intended effect, leading the juror to conclude that tPA would 
have helped the patient. 
A major feature of the trial was discussion of the EP’s 
documentation. Several points were examined. A review of 
systems was documented, but the EP was unable to recall at trial 
which questions he would have included. A National Institutes of 
Health Stroke Scale (NIHSS) was never documented, despite the 
hospital being a primary stroke center. The physician documented 
only that the patient had “normal movement and coordination,” 
but the family disputed that he had ever examined the patient. 
Similarly, when the patient’s symptoms changed, the EP 
documented “normal strength and sensation;” however, the 
family stated there was also slurred speech, which was neither 
confirmed nor denied by the EP’s chart. 
Most importantly, the initial chart presented in discovery for 
the trial was later found to have been altered by the EP once he 
learned the patient’s MRI results. The chart in question was an 
electronic medical record, in which the EP later overwrote his 
original chart to include the differential of CVA and state why he 
thought the presentation was more likely consistent with complex 
migraine. He did not address the potential use of tPA in either 
chart. He did not annotate that this was a change to the record 
being entered after the fact, when he had more information. 
The family specifically testified that they felt the EP was 
dismissive, did not examine or care about the patient, and did not 
discuss options with them.
The jury returned a $3.5 million verdict for the plaintiff, 
which is currently under appeal.
Case 2: Anonymous versus Anonymous – Kentucky
In a recently settled Kentucky case, a 43-year-old woman 
was celebrating on Christmas Eve with her family. There was 
no family discord or stress. She was witnessed to suddenly 
fall to the ground. The family noted that at approximately 
9:30 pm she could not speak and was unable to use her right 
arm. They brought her immediately to the ED. Upon arrival, 
she was evaluated by the EP at 10 pm. A CT of the brain was 
performed and read by the radiologist as normal at 10:48 pm. 
Nursing notes commented on the patient’s “unwillingness” to 
communicate and also that she moved her extremities when the 
family was not present. The EP failed to document a neurologic 
exam on the chart. The family repeatedly implored the EP to be 
concerned about the patient’s condition. The family testified that 
the EP stated, “Your daughter is having a nervous breakdown 
because of how you raised her.” The patient was admitted to the 
hospital with a diagnosis of conversion disorder. No neurologist 
was consulted, and administration of tPA was not considered. 
The next morning, the patient was seen by the admitting 
physician, who suspected that she had suffered a CVA. A repeat 
CT revealed a large, left middle cerebral artery infarct. The 
patient was immediately transferred to a tertiary care facility but 
unfortunately was left with dense motor and speech deficits. She 
was unable to return to work and the burden of her care led to 
divorce. The case was settled for an undisclosed sum.2
DISCUSSION
Dr. Moore: The time-sensitive administration of tPA is a 
“hot button” issue for many EPs. Controversy exists over the 
efficacy of the treatment, while providing treatment may 
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directly cause acute decompensation and poor outcomes. 
Furthermore, several well-known societies support the use of 
tPA, including the American Heart Association and American 
Stroke Association, which have deemed its administration 
“definitely recommended.”3 Subsequently, several societies 
including the American Academy of Emergency Medicine 
have decried this claim.4 This leaves EPs in a position of 
fearing complications and medicolegal litigation whether from 
action or inaction. 
In one retrospective cohort of 61,698 patients with acute 
ischemic stroke who presented within two hours of symptom 
onset, 25% of eligible patients failed to receive tPA treatment.5 
The reason for this finding is likely multifactorial and thought 
to be a combination of patient factors such as dementia or 
other underlying comorbid disorders, hospital factors such as 
ability to quickly rule out hemorrhagic stroke and initiate 
therapy with tPA, and lastly EP decision-making. “By far the 
most common reason cited, reported in more than half of the 
patients, was mild or rapidly improving symptoms. Among 
patients without a documented reason for not receiving tPA, 
mild stroke symptoms, defined as a NIHSS score less than 
five, were strongly associated with a lower likelihood of being 
treated. Prior studies have found that this is the most common 
reason given for not treating otherwise eligible patients with 
intravenous (IV) tPA, yet multiple cohorts have found that up 
to one-third of patients with mild stroke symptoms at 
presentation will have poor long-term outcomes.”5 
It can be easily extrapolated that EPs fear causing harm to 
a patient with mild symptoms; however, the risks associated 
with tPA are primarily applicable to patients who have already 
had an insult to brain tissue. In a study reviewing the effects of 
tPA in stroke mimics, 14% of their 521 patient cohort were 
ultimately diagnosed as stroke mimics after receiving tPA 
within three hours of symptom onset. None of these patients 
experienced intracranial hemorrhage. The most common 
stroke mimics were seizure, complex migraine, and 
conversion disorder.6
In addition to causing harm to a patient, EPs dread the 
outcome of litigation. In one study reviewing verdicts 
involving tPA, 33 cases were reviewed. The majority (N21; 
63.6%) decided in favor of the defendant providers. Of the 
remaining, nine (27.3%) resulted in plaintiff verdicts, two 
(6.1%) resulted in settlements, and one (3.0%) was an 
arbitration favorable to the plaintiff. Compensation for 
plaintiffs ranged from $100,000 to $30 million. The most 
common claim plaintiffs made was a failure of the treating 
physician to provide tPA (N29; 87.9%), with only three cases 
(9.1%) in which patients sued the providers and claimed that 
the use of tPA caused their injury. In general, plaintiffs also 
claimed failure or delay in stroke diagnosis (N22; 66.7%). 
Based on this review, it appears that most successful litigation 
resulted from EP delay in stroke diagnosis and/or failure to 
administer tPA.7 
A subsequent review confirmed these findings, where out 
of 40 applicable cases with available verdicts, the most 
frequent plaintiff claim was related to failure to administer IV 
tPA (38, 95%), and only two (5.0%) claims involved 
complications of treatment with tPA.8
As with many studies reviewing medicolegal verdicts, 
juries typically find in favor of the defendant physician, and 
this trend is also demonstrated with regard to tPA verdicts. 
Yet it appears that the number of cases is increasing. During 
the five years after tPA was approved by the United States 
Food and Drug Administration (1996 to 2001), there were 
only five cases, whereas from years six to ten (2002 to 
2007), 28 cases were reported.7
Another issue that becomes critical in regard to 
administration of tPA is informed consent. A possible 
explanation for the preponderance of plaintiffs’ success with 
“failure to treat” cases is that most often when patients 
receive tPA they have also given informed consent, whereas 
when tPA was withheld, patients have often not received the 
same guidance and opportunity to choose. In these cases, 
either the stroke was not identified, or the physician 
unilaterally chose for other reasons (contraindications, 
patient comorbidities, personal concerns about efficacy) not 
to administer tPA. In other words, informed consent is 
critical, and in cases where tPA was not given, the physician 
was more likely not to have obtained or documented 
informed consent regarding the decision.
“Regardless of one’s personal view regarding the efficacy 
and safety of tPA, it is essential to discuss and document with 
patient and family (surrogate) all treatment options. 
Maintaining legible, detailed and timely documentation as to 
time of onset, examination findings and informed consent why 
patients should or should not receive tPA should substantially 
reduce the threat of legal action.”9
Despite the medical concerns involved in the case, lessons 
apparent for EPs are to listen to the patient and his or her 
family, validate and discuss their concerns, ensure they are 
provided informed consent and that they understand the major 
decision points in the patient’s care. Subsequently, all care 
should be documented completely and accurately. 
Occasionally, the situation may occur where the EP knows 
more at the time of charting than he or she did at the time of 
the patient’s care, and it is the opinion of the authors that this 
is best approached with transparency. For example, a 
statement such as, “I am addending the chart and am at this 
point aware the patient had X outcome. I want to record 
additional thoughts, exam, and findings performed and 
considered, but not fully documented at the time of care,” may 
be an appropriate introduction. 
Dr. Stuart: Conversion disorder is characterized by 
neurologic symptoms causing distress but inconsistent with a 
specific medical or neurologic disease process. The diagnosis 
requires the following: altered motor or sensory function; 
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clinical findings demonstrating incompatibility between the 
symptom and recognized neurological and medical conditions; 
an explanation for the symptom that is not better explained by 
another medical or mental disorder; and, finally, the condition 
must cause clinically significant distress or impairment.10 
There is no requirement to identify psychological factors 
associated with the symptoms.  
A 2005 review of 27 studies found 4% of patients 
diagnosed were subsequently found to have a neurologic 
disorder.11 More recent studies demonstrate a lower incidence 
of misdiagnosis. Nonetheless, a diagnosis of conversion 
disorder introduces etiologic assumptions that often cannot be 
proven and should be made with extreme caution, if at all, in 
the ED.12 Patients may also be frightened by the effects of 
neurologic symptoms and exaggerate symptoms to convince a 
physician of their problem, creating a presentation suggestive 
of a conversion disorder. Patients with conversion disorder 
may also have an underlying neurologic disease similar to 
patients with psychogenic, non-epileptic seizures also having 
a concurrent seizure disorder in some cases.  
 Hemiplegic migraine describes a migraine headache 
accompanied by motor weakness during the aura phase. Motor 
weakness never occurs in isolation and is often accompanied 
by other forms of aura leading to impairment.13 Most patients 
with hemiplegic migraine have headaches of varying severity 
and some will have more severe attacks accompanied by 
encephalopathy or coma.14 It is a rare disorder with clinically 
indistinguishable familial and sporadic forms, which together 
occur in only 0.01% of the population.15 Motor and sensory 
findings more often involve the upper extremities, and upper 
motor findings such as a Babinski sign or unilateral hyper-
reflexia may be present during attacks.16 
Attacks typically last hours followed by normalization of 
the neurologic exam, but some patients with familial forms 
may also have cerebellar findings between attacks.14 The 
diagnosis is clinical, and the occurrence of episodic, reversible 
motor weakness as a manifestation of migraine aura in 
conjunction with at least one other kind of aura is 
required. This diagnosis of a rare disease with features 
indistinguishable on acute presentation from a CVA is further 
complicated because up to 27% of stroke patients have 
headache at onset.17
Several additional stroke mimics exist and comprise 
5-30% of patients initially diagnosed with stroke in the ED.18,19 
Ictal and post-ictal deficits are the most common mimic 
(13-20%) followed by toxic and metabolic disorders (18%, 
primarily hypoglycemia), syncope (8-15%), and sepsis 
(10%).19 Vertigo and nystagmus, although common neurologic 
symptoms encountered in the ED, are caused by a stroke 
3-10% of the time. Numerous additional stroke mimics exist 
with varying frequencies including, but not limited to, 
encephalopathies, mitochondrial disorders, multiple sclerosis, 
intracranial hemorrhage, reversible constriction syndromes, 
and transient global amnesia.20
Dr. Pfaff: Multiple studies have defined reasons that 
patients will initiate a malpractice action. One survey of 227 
patients who were initiating claims for medical malpractice 
noted the actions were not only for the injury but also because 
of poor communication and insensitive handling. Only 15% of 
explanations were deemed satisfactory. The four main reasons 
given for litigation were the following: 1) Concerns about 
competence and prevention of other patients being harmed; 2) 
to obtain an understanding and explanation of what happened; 
3) to obtain compensation to handle further medical care and 
permanent injury; and 4) to hold parties accountable for their 
actions.21 Another representative study linked the relationship 
of patient satisfaction to the likelihood of litigation. It reported 
on 353 physicians who had patient satisfaction surveys and 
ranked them into thirds. The middle third had a 26% higher 
chance of a malpractice action, while the lowest third had 
110% higher risk.22
The importance of documentation can’t be emphasized 
enough in order to prevent and defend a malpractice action. 
Prosecuting attorneys use charting deficiencies to show 
carelessness, sloppiness, and dishonesty. Physicians should 
realize they themselves have the ability to control and create 
the evidence and facts with proper documentation.23
In a recent illustrative case of CVA in Louisiana, in which 
a physician was accused of failing to give tPA, the jury stated 
it did not feel tPA was indicated. The physician claimed he 
discussed the issue with the patient’s wife, but there was no 
discussion documented on the chart. The jury in an interview 
later stated the $300,000 award was solely based on the lack 
of documentation of informed decision-making.24
Humphreys JD: The axiom “if it’s not charted, it’s not 
done” rings especially true in medical malpractice litigation, 
where the patient’s medical records are often the only way for 
a physician to prove that a patient’s treatment was carried out 
properly. A physician’s failure to document the completion of 
certain tests or assessments can serve as persuasive evidence 
in showing the physician failed to perform a complete 
workup. Additionally, a physician’s alteration of records can 
also help a plaintiff’s case, especially if the changes were 
made after the physician learned or should have learned of 
an adverse patient outcome, by suggesting the physician’s 
acknowledgment of an earlier medical error. These general 
truisms came into play in both of these cases.
CONCLUSION
When facing the possibility of a neurologic emergency 
in the ED, serious and debilitating possibilities should be 
considered, and rare conditions as well as those that can’t be 
confirmed with certainty should be less emphasized. It is 
imperative to both make a timely diagnosis and provide 
treatment for patients with a CVA. Physicians must also 
effectively communicate concerns and options to patients 
and their families (with documentation) to minimize 
subsequent litigation.
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Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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